The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method.

MLA

Perrone, Emanuele, et al. “The Immunohistochemical Molecular Risk Classification in Endometrial Cancer: A Pragmatic and High-Reproducibility Method.” Gynecologic Oncology, vol. 165, no. 3, June 2022, pp. 585–93. EBSCOhost, https://doi.org/10.1016/j.ygyno.2022.03.009.

APA

Perrone, E., De Felice, F., Capasso, I., Distefano, E., Lorusso, D., Nero, C., Arciuolo, D., Zannoni, G. F., Scambia, G., & Fanfani, F. (2022). The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method. Gynecologic Oncology, 165(3), 585–593. https://doi.org/10.1016/j.ygyno.2022.03.009

Chicago

Perrone, Emanuele, Francesca De Felice, Ilaria Capasso, Ettore Distefano, Domenica Lorusso, Camilla Nero, Damiano Arciuolo, Gian Franco Zannoni, Giovanni Scambia, and Francesco Fanfani. 2022. “The Immunohistochemical Molecular Risk Classification in Endometrial Cancer: A Pragmatic and High-Reproducibility Method.” Gynecologic Oncology 165 (3): 585–93. doi:10.1016/j.ygyno.2022.03.009.